Ambalal Sarabhai Ent
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Nov 20 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES LTD - TELERAD DIVISION OF UNIT SIGNS AGREEMENT WITH BOLIN TECHNOLOGY
Further company coverage: AMBL.BO
(([email protected];))
Nov 20 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES LTD - TELERAD DIVISION OF UNIT SIGNS AGREEMENT WITH BOLIN TECHNOLOGY
Further company coverage: AMBL.BO
(([email protected];))
May 1 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES - CFO NAVINCHANDRA PATEL RESIGNS
Source text for Eikon: ID:nBSE2nDWx6
Further company coverage: AMBL.BO
(([email protected];))
May 1 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES - CFO NAVINCHANDRA PATEL RESIGNS
Source text for Eikon: ID:nBSE2nDWx6
Further company coverage: AMBL.BO
(([email protected];))
Aug 24 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
NAMES MOHAL K. SARABHAI AS MD
Source text for Eikon: ID:nBSE9thFtH
Further company coverage: AMBL.BO
(([email protected];;))
Aug 24 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
NAMES MOHAL K. SARABHAI AS MD
Source text for Eikon: ID:nBSE9thFtH
Further company coverage: AMBL.BO
(([email protected];;))
June 9 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES LTD - UNIT ASENCE PHARMA COMMENCES NEW ONCOLOGY AND SYNTHETIC API PLANT AT RANOLI, VADODARA
Source text for Eikon: [ID:]
Further company coverage: AMBL.BO
(([email protected];))
June 9 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES LTD - UNIT ASENCE PHARMA COMMENCES NEW ONCOLOGY AND SYNTHETIC API PLANT AT RANOLI, VADODARA
Source text for Eikon: [ID:]
Further company coverage: AMBL.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Ambalal Sarabhai Ent do?
Established in 1978, Ambalal Sarabhai Enterprises Limited, commonly known as Sarabhai, is a prominent manufacturer in the Indian pharmaceutical industry.
Who are the competitors of Ambalal Sarabhai Ent?
Ambalal Sarabhai Ent major competitors are Gennex Laboratories, Lyka Labs, Coral Laboratories, Brooks Laboratories, Vaidya Sane Ayur Lab, Achyut Healthcare, Trident Lifeline. Market Cap of Ambalal Sarabhai Ent is ₹240 Crs. While the median market cap of its peers are ₹215 Crs.
Is Ambalal Sarabhai Ent financially stable compared to its competitors?
Ambalal Sarabhai Ent seems to be less financially stable compared to its competitors. Altman Z score of Ambalal Sarabhai Ent is 2.38 and is ranked 8 out of its 8 competitors.
Does Ambalal Sarabhai Ent pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ambalal Sarabhai Ent latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Ambalal Sarabhai Ent allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Accounts Receivable
How strong is Ambalal Sarabhai Ent balance sheet?
Balance sheet of Ambalal Sarabhai Ent is moderately strong.
Is the profitablity of Ambalal Sarabhai Ent improving?
The profit is oscillating. The profit of Ambalal Sarabhai Ent is ₹17.8 Crs for Mar 2026, ₹4.93 Crs for Mar 2025 and ₹5.68 Crs for Mar 2024
Is the debt of Ambalal Sarabhai Ent increasing or decreasing?
The net debt of Ambalal Sarabhai Ent is decreasing. Latest net debt of Ambalal Sarabhai Ent is ₹12.9 Crs as of Mar-26. This is less than Mar-25 when it was ₹25.61 Crs.
Is Ambalal Sarabhai Ent stock expensive?
Ambalal Sarabhai Ent is not expensive. Latest PE of Ambalal Sarabhai Ent is 13.49, while 3 year average PE is 34.46. Also latest EV/EBITDA of Ambalal Sarabhai Ent is 23.15 while 3yr average is 42.49.
Has the share price of Ambalal Sarabhai Ent grown faster than its competition?
Ambalal Sarabhai Ent has given lower returns compared to its competitors. Ambalal Sarabhai Ent has grown at ~2.7% over the last 3yrs while peers have grown at a median rate of 15.12%
Is the promoter bullish about Ambalal Sarabhai Ent?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Ambalal Sarabhai Ent is 31.36% and last quarter promoter holding is 31.36%.
Are mutual funds buying/selling Ambalal Sarabhai Ent?
There is Insufficient data to gauge this.